Word

ZYLORION

Status

Pending

Status Code

653

Status Date

Thursday, October 19, 2023

Serial Number

97102047

Mark Type

4000

Filing Date

Monday, November 1, 2021

Trademark Owner History

PsiloTec Health Solutions Inc.

Classifications

41 Provision of training in the fields of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes; provision of education services, namely, providing courses of instruction, classes, seminars, workshops, and conferences in the fields of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes; provision of training in the field of psychedelic medicines; provision of education services, namely, providing courses of instruction, classes, seminars, workshops, and conferences and training in the field of psychedelic medicines

9 Downloadable computer application software for mobile phones for clinical interactions, scheduling appointments, submitting feedback, measuring feedback from biometrics, such as pulse and heart rate, and storing forms and questionnaires in connection with providing therapy services to individuals in the fields of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes; downloadable computer software for clinical interactions, scheduling appointments, submitting feedback, measuring feedback from biometrics, such as pulse and heart rate, and storing forms and questionnaires in connection with providing therapy services to individuals in the fields of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes

29 Dried edible mushrooms

5 Psychedelic medicines for the treatment of psychiatric diseases, namely, mood disorders, depression, mood and emotional instability disorders; psychedelic medicines for the treatment of addiction disorders, namely, alcohol abuse, drug abuse, eating disorders, gambling addiction and sex addiction; psychedelic medicines for the treatment of anxiety disorders, namely, social anxiety, generalized anxiety and panic attack disorder; psychedelic medicines for the treatment of psychological trauma, namely, post-traumatic stress disorder, occupational stress injury, bullying, emotional trauma, physical trauma, work trauma, family violence and grief; psychedelic medicines for the treatment of physical trauma, namely, post-burn injury, post-spinal-cord injury, adult post-amputation, post-brain injury and post-stroke; psychedelic medicines for the treatment of chronic pain, namely, migraines, chronic back pain and chronic arthritis; psychedelic medicines for the treatment of cognitive diseases, namely, cognitive deterioration, early dementia and age-associated memory impairment; psychedelic medicines for the treatment of neuropsychiatric disorders, namely, adult fetal alcohol spectrum disorder, adult attention deficit disorder, adult autism, post-stroke symptoms, multiple sclerosis and Parkinson's disease; psychedelic medicines for the treatment of sleep related disorders, namely, chronic fatigue syndrome, fatigue and insomnia; psychedelic medicines for the treatment of mental health problems experienced by indigenous and other marginalized communities; psychedelic medicines for the treatment of covid-19 symptoms and syndromes

35 Data processing services of medical data relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes; compiling medical data for business purposes relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes

44 Psychotherapy services; mental health therapy services for the treatment of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes; provision of information to others in the field of mental health; clinical mental health counselling services; compiling medical health information data in the fields of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes

31 Fresh edible mushrooms

42 Medical and scientific research and product development in the field of psychedelics; medical and scientific research in the fields of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the fields of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes; laboratory scientific and medical research in the fields of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes; providing temporary use of non-downloadable computer software for clinical interactions, scheduling appointments, submitting feedback, measuring feedback from biometrics, such as pulse and heart rate, and storing forms and questionnaires in connection with providing therapy services to individuals in the fields of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes; compiling medical and scientific research data in the fields of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, and covid-19 symptoms and syndromes

Trademark Events

Oct 19, 2023

Notification Of Letter Of Suspension E-Mailed

Oct 19, 2023

Letter Of Suspension E-Mailed

Oct 19, 2023

Suspension Letter Written

Oct 19, 2023

Teas/Email Correspondence Entered

Oct 19, 2023

Correspondence Received In Law Office

Oct 19, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Oct 19, 2023

Assigned To Lie

May 22, 2023

Teas Response To Suspension Inquiry Received

Feb 23, 2023

Teas Change Of Correspondence Received

Feb 23, 2023

Teas Withdrawal Of Attorney Received-Firm Retains

Feb 23, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Feb 23, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Feb 22, 2023

Notification Of Inquiry As To Suspension E-Mailed

Feb 22, 2023

Inquiry To Suspension E-Mailed

Feb 22, 2023

Suspension Inquiry Written

Aug 25, 2022

Notification Of Letter Of Suspension E-Mailed

Aug 25, 2022

Letter Of Suspension E-Mailed

Aug 25, 2022

Suspension Letter Written

Aug 20, 2022

Teas/Email Correspondence Entered

Aug 19, 2022

Correspondence Received In Law Office

Aug 19, 2022

Teas Response To Office Action Received

Aug 12, 2022

Notification Of Non-Final Action E-Mailed

Aug 12, 2022

Non-Final Action E-Mailed

Aug 12, 2022

Non-Final Action Written

Aug 10, 2022

Assigned To Examiner

Nov 11, 2021

New Application Office Supplied Data Entered

Nov 4, 2021

New Application Entered